Literature DB >> 31356494

SEVERITY OF DIABETIC MACULAR EDEMA CORRELATES WITH RETINAL VASCULAR BED AREA ON ULTRA-WIDE FIELD FLUORESCEIN ANGIOGRAPHY: DAVE Study.

Wenying Fan1,2,3, Akihito Uji2,3, Kang Wang2,3, Khalil Ghasemi Falavarjani2,3, Charles C Wykoff4,5, David M Brown4,5, Jano Van Hemert6, Min Sagong2,3, Srinivas R Sadda2,3, Michael Ip2,3.   

Abstract

PURPOSE: To quantify retinal nonperfusion area and retinal vascular bed area (RVBA) in mm on ultra-widefield fluorescein angiography in eyes with diabetic macular edema (DME) and explore their relationship with the severity of DME.
METHODS: Prospective, observational case series. Baseline ultra-widefield fluorescein angiography images of 40 eyes from 29 patients with treatment-naive DME who participated in the DAVE study (NCT01552408) were stereographically projected at Doheny Image Reading Center. The retinal vasculature was automatically extracted to calculate RVBA. Nonperfusion area was manually delineated by two masked certified graders. Retinal vascular bed area and nonperfusion area were computed in mm automatically by adjusting for peripheral distortion and then correlated with the severity of DME.
RESULTS: The global RVBA for the entire retina in eyes with DME was increased compared with healthy controls (54.7 ± 16.6 mm vs. 37.2 ± 9.9 mm, P < 0.001) and correlated with the severity of DME (P < 0.05). Retinal ischemia (nonperfusion area) was nonuniformly distributed and not related to DME extent (P > 0.05).
CONCLUSION: Eyes with DME have an increased RVBA compared with healthy controls. The severity of DME appears to be related to global RVBA, but not to retinal ischemia.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31356494     DOI: 10.1097/IAE.0000000000002579

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  7 in total

Review 1.  Retinal non-perfusion in diabetic retinopathy.

Authors:  Charles C Wykoff; Hannah J Yu; Robert L Avery; Justis P Ehlers; Ramin Tadayoni; SriniVas R Sadda
Journal:  Eye (Lond)       Date:  2022-01-11       Impact factor: 3.775

2.  Early Visual Functional Outcomes and Morphological Responses to Anti-Vascular Growth Factor Therapy in Diabetic Macular Oedema Using Optical Coherence Tomography Angiography.

Authors:  Supriya Dabir; Mohan Rajan; Liji Parasseril; Vaidehi Bhatt; Preetam Samant; C A B Webers; T T J M Berendschot
Journal:  Clin Ophthalmol       Date:  2021-01-28

3.  Optical coherence tomography and imaging biomarkers as outcome predictors in diabetic macular edema treated with dexamethasone implant.

Authors:  Hung-Da Chou; Cheng-Hsiu Wu; Wei-Yu Chiang; Nan-Ni Chen; Yih-Shiou Hwang; Kuan-Jen Chen; Chien-Hsiung Lai; Pei-Chang Wu; Yi-Hao Chen; Ling Yeung; Shih-Chieh Shao; Chi-Chun Lai; Wei-Chi Wu
Journal:  Sci Rep       Date:  2022-03-09       Impact factor: 4.379

4.  Differentiating features of OCT angiography in diabetic macular edema.

Authors:  Reza Mirshahi; Hamid Riazi-Esfahani; Elias Khalili Pour; Kaveh Fadakar; Parsa Yarmohamadi; Sayyed Amirpooya Alemzadeh; Samira Chaibakhsh; Khalil Ghasemi Falavarjani
Journal:  Sci Rep       Date:  2021-12-03       Impact factor: 4.379

Review 5.  Progress of Imaging in Diabetic Retinopathy-From the Past to the Present.

Authors:  Shintaro Horie; Kyoko Ohno-Matsui
Journal:  Diagnostics (Basel)       Date:  2022-07-11

6.  Living Without a Diagnosis: A Patient's Perspective on Diabetic Macular Ischemia.

Authors:  Jacqueline D Humphreys; Sobha Sivaprasad
Journal:  Ophthalmol Ther       Date:  2022-07-12

Review 7.  Ultrawide Field Imaging in Diabetic Retinopathy: Exploring the Role of Quantitative Metrics.

Authors:  Mohamed Ashraf; Jerry D Cavallerano; Jennifer K Sun; Paolo S Silva; Lloyd Paul Aiello
Journal:  J Clin Med       Date:  2021-07-27       Impact factor: 4.964

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.